PAX Financial Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,361
Closed -$446K 187
2022
Q1
$446K Buy
+6,361
New +$446K 0.1% 144